Protein Dossier — GDF11 (Growth/differentiation factor 11)
MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).
1. Published MR estimates (retrieved, not computed)
| Outcome |
beta |
se |
p |
method |
nSNP |
cis/trans |
coloc |
| Body mass index (BMI) |
-0.0539 |
0.0101 |
1.06e-07 |
Inverse variance weighted |
2 |
trans |
0.0313 |
| Body mass index (BMI) |
-0.0539 |
0.0101 |
1.06e-07 |
Inverse variance weighted |
2 |
trans |
0.139 |
| Eczema |
0.264 |
0.0718 |
2.32e-04 |
Inverse variance weighted |
2 |
trans |
NA |
| Eczema |
0.264 |
0.0718 |
2.32e-04 |
Inverse variance weighted |
2 |
trans |
NA |
| Ulcerative colitis |
-0.222 |
0.0773 |
0.00412 |
Wald ratio |
1 |
trans |
NA |
| Lung adenocarcinoma |
-0.297 |
0.116 |
0.0107 |
Inverse variance weighted |
2 |
trans |
NA |
| Lung adenocarcinoma |
-0.297 |
0.116 |
0.0107 |
Inverse variance weighted |
2 |
trans |
NA |
| Diagnoses - main ICD10: D25 Leiomyoma of uterus |
-0.304 |
0.123 |
0.0139 |
Inverse variance weighted |
2 |
trans |
NA |
| Diagnoses - main ICD10: D25 Leiomyoma of uterus |
-0.304 |
0.123 |
0.0139 |
Inverse variance weighted |
2 |
trans |
NA |
| Diastolic blood pressure automated reading |
-0.0243 |
0.0104 |
0.0192 |
Inverse variance weighted |
2 |
trans |
NA |
| Diastolic blood pressure automated reading |
-0.0243 |
0.0104 |
0.0192 |
Inverse variance weighted |
2 |
trans |
NA |
| Neuroblastoma |
-0.407 |
0.182 |
0.0258 |
Inverse variance weighted |
2 |
trans |
NA |
| …and 187 more outcomes (see JSON) |
|
|
|
|
|
|
|
2. pQTL instrument availability (Tier-B probe)
| Dataset |
Trait |
Author |
Year |
prot-c-2765_4_3 |
GDF-11 |
Suhre K |
2019 |
3. GWAS Catalog results — traits with signal at this locus
2 association rows across 2 traits (2 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.
| Trait |
best p |
lead SNP |
n assoc |
study |
MR status |
| CD63 protein levels |
2e-18 |
rs188443236 |
1 |
GCST90468642 |
no MR -> candidate analysis |
| Circulating CD63 levels |
5e-18 |
rs188443236 |
1 |
GCST90860756 |
no MR -> candidate analysis |
4. Phenome map — where this gene is a genetic locus, vs. where MR exists
Top diseases by Open Targets association (of 2457 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.
| Disease |
genetic assoc. |
burden (ExWAS) |
causal status |
MR status |
| vertebral hypersegmentation and orofacial anomalies |
0.58 |
— |
established (curated) |
no MR -> candidate analysis |
| orofacial cleft |
0.426 |
— |
established (curated) |
no MR -> candidate analysis |
| neurodevelopmental disorder |
0.195 |
— |
established (curated) |
no MR -> candidate analysis |
Of the 3 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.
5. Downstream annotation (druggability & safety preview)
| Layer |
Result |
| ChEMBL druggability |
not available — no ChEMBL target (undrugged) |
| gnomAD constraint |
pLI=0.86, LOEUF=0.565 — LoF-tolerant |
| GWAS Catalog |
27 unique SNPs / 54 rows |
| ClinVar |
61 records; 1 pathogenic in sample of 30 |
| PharmGKB/ClinPGx |
no annotations |
phenome — Top 30 of 2457 associated diseases by overall score. genetic_association aggregates GWAS common-variant AND rare-variant evidence. These are ASSOCIATIONS (loci), not causal claims.chembl — No ChEMBL target for ‘GDF11’.clinvar — Pathogenic count is over the 30 record(s) retrieved, NOT over all 61 ClinVar records for this gene; it is a sample, not a rate.pharmgkb — No PharmGKB/ClinPGx clinical annotations (gene may not be a pharmacogene).gwas_traits — Top 2 of 2 traits by best p-value, aggregated from 2 association rows. These are GWAS ASSOCIATIONS (loci), not causal claims; mapped genes at a locus are not necessarily the effector gene.
Sources
uniprot: https://www.uniprot.org/uniprotkb/O95390 — UniProt release 2026_02 (10-June-2026)mr_outcomes: https://epigraphdb.org/pqtl/ — EpiGraphDB pQTL MR (Zheng et al., Nat Genet 2020) — pre-computed two-sample MR; retrieved, not computed by this agent; EpiGraphDB build 1.0, pQTL dataset v3.0phenome: https://platform.opentargets.org/target/ENSG00000135414/associations — Open Targets data release 26.06gnomad: https://gnomad.broadinstitute.org/gene/GDF11 — gnomAD constraint via GraphQL API (reference genome GRCh38)gwas: https://www.ebi.ac.uk/gwas/genes/GDF11 — GWAS Catalog REST (live; release not exposed by this endpoint)clinvar: https://www.ncbi.nlm.nih.gov/clinvar/?term=GDF11%5Bgene%5D — ClinVar build Build260809-1055.1gwas_traits: https://www.ebi.ac.uk/gwas/genes/GDF11 — GWAS Catalog search API (live; release not exposed)
Provenance
- Generated: 2026-08-14T02:47:05 · Tier: A
- Fully mechanical: every cell above is rendered from tool return values. No language model wrote any part of this dossier.
- MR estimates, where present, are retrieved from published work (EpiGraphDB pQTL, Zheng et al. Nat Genet 2020); nothing is computed here.
- Tool errors this run: none